Art. 4 Further definitions
1 In this Ordinance: - a.
- making available on the market means any transfer or cession of a device, other than an investigational device, for distribution, consumption or use on the Swiss market in the course of a commercial activity, whether in return for payment or free of charge;
- b.
- placing on the market means the first making available of a device, other than an investigational device, on the Swiss market;
- c.
- putting into service means the stage at which a device, other than an investigational device, has been made available to the final user as being ready for use on the Swiss market for the first time for its intended purpose;
- d.
- maintenance means measures such as preventive maintenance, software updates, inspection, repair, preparation for first use and reprocessing for reuse or measures to keep a device in functional condition or restore it to functional condition;
- e.
- reprocessing means a process carried out on a used device in order to allow its safe reuse including cleaning, disinfection, sterilisation and related procedures, particularly packing, transport and storage, as well as testing and restoring the technical and functional safety of the used device;
- f.
- manufacturer means a natural or legal person who manufactures or fully refurbishes a device or has a device designed, manufactured or fully refurbished, and markets that device under its name or trademark; this definition is subject to the clarifying explanations and exceptions in Article 16 paragraphs 1 and 2 of Regulation (EU) 2017/74511 on medical devices (EU-MDR);
- g.
- authorised representative means any natural or legal person domiciled in Switzerland who has received and accepted a written mandate from a manufacturer located in another country to act on the manufacturer's behalf in relation to specified tasks with regard to the latter's obligations under this Ordinance;
- h.
- importer means any natural or legal person domiciled in Switzerland that places a device from a foreign country on the Swiss market;
- i.
- distributor means any natural or legal person in the supply chain, other than the manufacturer or the importer, that makes a device available on the Swiss market, up until the point of putting into service;
- j.
- economic operator means the manufacturer, authorised representative, importer, distributor or the natural or legal person referred to in Article 22 paragraphs 1 and 3 EU-MDR;
- k.
- healthcare institution means an organisation the primary purpose of which is the care or treatment of patients or the promotion of public health;
- l.
- hospitalmeans any healthcare institution in which inpatient treatments for illnesses, inpatient medical rehabilitation and inpatient medical measures for cosmetic purposes are provided by medical or nursing interventions;
- m.
- contracting state means any state that is bound to mutually recognise conformity assessments and conformity procedures for devices by an agreement with Switzerland under international law based on equivalent legislation;
- n.12
- provider of information society servicesmeans any natural or legal person who provides a service in accordance with Article 7 paragraph 4.
2 The definitions set out in Article 2 numbers 3–26, 31, 37, 38, 40–44, 46, 48, 51–53, 57–69 and 71 EU-MDR, taking account of the amendments to the definitions in Article 2 numbers 18–21 EU-MDR, adopted by the European Commission by means of delegated acts13. 11 Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC, OJ L117 of 5.5. 2017, p. 1; last amended by Regulation (EU) 202/561, OJ L 130 of 24.4.2020, p. 18. 12 Inserted by Annex 5 No 1 of the O of 4 May 2022 on In Vitro Diagnostic Medical Devices, in force since 26 May 2022 (AS 2022 291). 13 See Annex 4.
BGE
133 V 115 () from 11. Dezember 2006
Regeste: Art. 32 Abs. 1 und 2 KVG: Nachweis der Wirksamkeit einer medizinischen Behandlung. Anforderungen an das für die Kostenübernahmepflicht des obligatorischen Krankenpflegeversicherers erforderliche Kriterium der Wirksamkeit einer medizinischen Massnahme (in casu einer zahnärztlichen Implantatversorgung; E. 3).
|